AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Atrae, Inc. Develops People Tech solutions for HR, including big data job sites and organizational analytics.	Japan	6194
Aura Energy Limited Developing uranium and battery minerals for the nuclear energy and energy storage markets.	Australia	AEE
Avalo Therapeutics, Inc. Clinical-stage biotech developing IL-1β therapies for immune inflammatory diseases.	United States of America	AVTX
AVIS BUDGET GROUP, INC. Global provider of car rental, truck rental, and car-sharing for business & leisure travelers.	United States of America	CAR
Azenta, Inc. Life science solutions for pharma & biotech, offering sample management, storage & multiomics.	United States of America	AZTA
BayCurrent, Inc. Comprehensive consulting on strategy, AI, and digital transformation for corporations and government.	Japan	6532
BenevolentAI An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.	United Kingdom	BAI
BerGenBio Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.	Norway	BGBIO
Bergman & Beving Acquires and develops niche companies with solutions for the industrial and construction sectors.	Sweden	BERG
Bestone.Com Co.,Ltd An online travel agency specializing in domestic and overseas cruise tours and tickets.	Japan	6577